CA 19-9 and CEA are the most commonly used biomarkers for diagnosis and management
of patients with pancreatic cancer. Since the original compendium by Steinberg in 1990 …

BACKGROUND: Although many biochemical markers have been examined in pancreatic
cancer none are definitive for pre-operative diagnosis. This systematic review examines …

Background Serum carbohydrate antigen (CA 19-9) is the most common tumor marker
assessed in pancreatic cancer patients; nevertheless few articles have comprehensively …

Monoclonal antibodies are used to detect serum antigens associated with specific
malignancies. These tumor markers are most useful for monitoring response to therapy and …

Hilar cholangiocarcinoma (HCCA) is one of the most common types of hepatobiliary cancers
reported in the world including A sia–P acific region. Early HCCA may be completely …

Pancreatic cancer is an aggressive tumor with a dismal prognosis, biomarkers that can
detect tumor in its early stages when it may be amenable to curative resection may improve …

Biliary strictures present a diagnostic challenge, especially when no etiology can be
ascertained after laboratory evaluation, abdominal imaging and endoscopic retrograde …

BACKGROUND: Obstructive jaundice is frequently associated with false CA19-9 elevation in
benign conditions. The diagnostic accuracy of this tumor marker was evaluated in the …

Cholangiocarcinoma is a primary hepatic malignancy originating from bile duct epithelium. It
is the second most common primary hepatic neoplasia, and its incidence has increased …

Methods A total of 1,377 patients, who were diagnosed with primary cholangiocarcinoma
between 1996 and 2002, were reviewed retrospectively according to the following inclusion …